Synthesis and Antidepressant Properties of 3-Methyl-7-(1,1-Dioxothietan-3-YL)-8-Cyclohexylamino-1-Ethyl-1H-Purine-2,6(3H,7H)-Dione
- Authors: Khaliullin F.A.1, Shabalina Y.V.1, Davlyatova G.G.1, Valeeva L.A.1
- 
							Affiliations: 
							- Bashkir State Medical University, Ministry of Health of the RF, Ufa
 
- Issue: Vol 51, No 12 (2018)
- Pages: 1049-1052
- Section: Search for New Drugs
- URL: https://ogarev-online.ru/0091-150X/article/view/244908
- DOI: https://doi.org/10.1007/s11094-018-1738-0
- ID: 244908
Cite item
Abstract
3-Methyl-7-(1,1-dioxothietan-3-yl)-8-cyclohexylamino-1-ethyl-1H-purine-2,6(3H,7H)-dione was synthesized via the reaction of 8-bromo-3-methyl-7-(1,1-dioxothietan-3-yl)-1-ethyl-1H-purine-2,6(3H,7H)-dione and cyclohexylamine and exhibited antidepressant activity that was most pronounced at a dose of 1.6 mg/kg.
Keywords
About the authors
F. A. Khaliullin
Bashkir State Medical University, Ministry of Health of the RF, Ufa
														Email: chem@folium.ru
				                					                																			                												                	Russian Federation, 							Bashkortostan, 450008						
Yu. V. Shabalina
Bashkir State Medical University, Ministry of Health of the RF, Ufa
														Email: chem@folium.ru
				                					                																			                												                	Russian Federation, 							Bashkortostan, 450008						
G. G. Davlyatova
Bashkir State Medical University, Ministry of Health of the RF, Ufa
														Email: chem@folium.ru
				                					                																			                												                	Russian Federation, 							Bashkortostan, 450008						
L. A. Valeeva
Bashkir State Medical University, Ministry of Health of the RF, Ufa
														Email: chem@folium.ru
				                					                																			                												                	Russian Federation, 							Bashkortostan, 450008						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					